Company Filing History:
Years Active: 2009
Title: Ian Harold Smith: Innovator in the Field of Thienopyridone Derivatives
Introduction: Ian Harold Smith, an accomplished inventor based in Kings Langley, GB, is recognized for his innovative contributions to the realm of chemical compounds. His work focuses on developing unique derivatives that can play a significant role in medical applications.
Latest Patents: Ian holds a notable patent for a "Process for preparing 3-aminothienopyridone derivatives." This invention introduces a class of 3-amino-7H-thieno[2,3-b]pyridin-6-one derivatives that are specifically substituted in the 7-position by an aryl, heteroaryl, cycloalkyl, or heterocycloalkyl moiety. The patent also details a process for preparing these compounds, which are anticipated to serve as intermediates in the manufacture of specific p38 MAP kinase inhibitors.
Career Highlights: Ian is currently affiliated with Celltech R&D Limited, where he utilizes his expertise to push the boundaries of pharmaceutical research and development. His contributions in the field highlight his commitment to advancing therapeutic solutions through innovative chemical processes.
Collaborations: Throughout his professional journey, Ian has worked alongside esteemed colleagues such as Graham Robert Evans and Neil Tremayne. These collaborations have fostered an environment of creativity and scientific exploration, further enhancing the impact of their collective research.
Conclusion: Ian Harold Smith's work exemplifies the dynamic nature of innovation in the pharmaceutical industry. With his patented processes and collaborations, he continues to pave the way for advancements that hold promise for future medical applications, reaffirming his status as an influential inventor in his field.